Amanta Healthcare Ltd IPO

Amanta Healthcare Ltd IPO

Pharmaceuticals

mainboard

Pre-apply

Bidding period

01 Sep 2025 - 03 Sep 2025

Bid price

₹120.00 - ₹126.00

Listing on

BSE, BSE, NSE

Listing date

09 Sep 2025

Lot size

119 shares

Issue size

₹126.00 crore


Minimum investment

₹14,994.00 / 1 lot

Maximum investment

₹1,94,922.00 / 13 lot

Bidding starts tomorrow

PRE-APPLY FOR IPO
PRE-APPLY FOR IPO

Amanta Healthcare Ltd IPO dates

IPO opening date

01 Sep 2025

IPO end date

03 Sep 2025

Allotment date

04 Sep 2025

Initiation of refunds

08 Sep 2025

Credit of shares to demat

08 Sep 2025

IPO listing date

09 Sep 2025

Amanta Healthcare Ltd IPO financials

Particulars

For the period ending in March 2024 (in ₹ million)

Total assets ₹352.12
Total liabilities ₹352.12
Total expenditure ₹276.22
Total revenue ₹281.61
Profit after tax ₹3.63
EBITDA ₹58.76
Adjusted EBITDA ₹0.00

Amanta Healthcare Ltd shareholder pattern

Pre-issue Post-issue
Promoter group 85.6 63.56
Public group 14.4 36.44

Amanta Healthcare Ltd strengths and risks

Information currently unavailable

  • Well established manufacturer of pharmaceutical formulations with diverse product portfolio and diverse market.

  • Large manufacturing capabilities.

  • Wide Domestic and International Marketing Network.

  • Experienced management team supported by large, diverse and skilled work force.

  • Our Company's entire manufacturing facility is located at a single location, and all of the Company's manufactured products are produced from such facility in village Hariyala, district Kheda, Gujarat. Any delay in production at, or shutdown of, our manufacturing facility due to various factors such as shortage of electrical power or water resources, political instability, industrial accidents or machinery breakdowns, severe weather conditions, natural disasters, and outbreak of infectious diseases may in turn adversely affect our business, financial condition and results of operations.

  • Any manufacturing or quality control concerns or our inability to deliver products on a timely basis, or at all, could result in the cancellation of purchase orders, breaches of relevant agreements, and termination of agreements by our clients and distributors, which could have an adverse effect on our business, results of operations, financial condition and cash flows.

  • Our Company is involved in a certain material litigation and an adverse outcome in this proceeding may adversely affect our business, financial condition and growth strategy.

  • We may not be able to improve our profit margins and profits in the future.

  • Our Company had issued Equity Shares to more than 49 investors in the past and as a matter of abundant caution for better corporate governance, our Company has given an exit offer to the eligible shareholders.

  • Finance cost of the Company has been very high and finance cost of the company for the Fiscal 2025, Fiscal 2024, and Fiscal 2023 constituted 45.78%, 57.25% and 62.64% of the Restated Earnings before interest, tax, depreciation and amortization (EBITDA). If company is unable to control the finance cost in future, it may adversely affect business, results of operations, financial condition and cash flows.

  • Our operations are labour intensive, and we may be subject to strikes, work stoppages or increased wage demands by our employees, increase in minimum wages across various states and we may also be unable to engage new employees at commercially attractive terms which could adversely affect our business, results of operations and financial condition.

  • We rely on limited suppliers for our raw material i.e., LDPE (Low Density Polyethylene) and PP granules (Polypropylene). The prices of LDPE and PP granules are volatile and largely linked to crude price volatility. Loss of these suppliers, or any fluctuation in the prices of these raw materials may have an adverse effect on our business, results of operations and financial conditions.

  • The Issue Price, market capitalisation to revenue multiple and price to earnings ratio of our Company based on the Issue Price may not be indicative of the market price of our Company on listing or thereafter or indicative of such multiples and ratios based on the market price of the Equity Shares on listing or thereafter.

  • Our manufacturing license has been suspended in the past and any such suspensions in the future could adversely affect our business, results of operations, financial condition and cash flows.

How to check the allotment status of the Amanta Healthcare Ltd IPO?

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘Amanta Healthcare Ltd’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

Read more Read less

Amanta Healthcare Ltd IPO registrar

MUFG Intime India Pvt Ltd

Phone number +91 8108114949
E-mail ID amantahealthcare.ipo@linkintime.co.in
Website www.linkintime.co.in

Amanta Healthcare Ltd IPO reservation

QIB shares offered

20,00,000 (20.0%)

NII (HNI) shares offered

15,00,000 (15.0%)

Retail shares offered

35,00,000 (35.0%)

Anchor investor shares offered

30,00,000 (30.0%)

Total shares offered

1,00,00,000

Total shares with anchor investor

1,00,00,000

Amanta Healthcare Ltd IPO lead manager

  • Beeline Capital Advisors Pvt Ltd

Explore other IPOs

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Amanta Healthcare Ltd IPO?

The listing date for the Amanta Healthcare Ltd IPO is 09 Sep 2025.

What is the issue size of Amanta Healthcare Ltd IPO?

The issue size of the Amanta Healthcare Ltd IPO is ₹126.00 cr.

What is the minimum lot size needed for Amanta Healthcare Ltd IPO?

The minimum lot size for Amanta Healthcare Ltd IPO is 119

When does the Amanta Healthcare Ltd open and close?

Amanta Healthcare Ltd IPO is open from 01 Sep 2025 to 03 Sep 2025.

How can I apply for the Amanta Healthcare Ltd IPO?

To apply for the Amanta Healthcare Ltd, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)